信达生物:陈树云获指派为首席独立非执行董事

格隆汇
31 Mar

格隆汇3月31日丨信达生物(01801.HK)发布公告,自2025年3月31日起:(a)独立非执行董事许懿尹已获委任为董事会提名委员会成员。许女士于董事会及相关董事委员会的其他职位维持不变;及(b)独立非执行董事陈树云已获指派为首席独立非执行董事。首席独立非执行董事并非公司行政职务,在集团亦无任何管理职能。陈先生于董事会及相关董事委员会的其他职位维持不变。【免责声明】本文仅代表作者本人观点,与...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10